Paradigm Biocapital Advisors LP Bridge Bio Pharma, Inc. Transaction History
Paradigm Biocapital Advisors LP
- $2.14 Billion
- Q2 2025
A detailed history of Paradigm Biocapital Advisors LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Paradigm Biocapital Advisors LP holds 965,764 shares of BBIO stock, worth $60.6 Million. This represents 1.95% of its overall portfolio holdings.
Number of Shares
965,764Holding current value
$60.6 Million% of portfolio
1.95%Shares
2 transactions
Others Institutions Holding BBIO
# of Institutions
419Shares Held
187MCall Options Held
11.3MPut Options Held
1.93M-
Viking Global Investors LP18.6MShares$1.16 Billion2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$1.06 Billion0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$832 Million22.63% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$781 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X09.28MShares$582 Million0.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $9.3B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...